Pediatric COVID-19 Vaccines
Award Notice Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75D30123D16651
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Pfizer Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30123D16651 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention awarded a $782 million contract to Pfizer Inc. on June 7, 2023 for pediatric COVID-19 vaccines. The contract was awarded without a set-aside through the Department of Health and Human Services Office of Acquisition Services to provide COVID-19 vaccines for children through Pfizer. The significant value of this sole source contract indicates a substantial quantity of pediatric vaccines will be delivered under its terms.
Notice text
Awarded contract 75D30123D16651 to PFIZER INC for 782000000.00 on 2023-06-07.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pediatric COVID-19 Vaccines | Limited / Sole Source Justification | |
| Pediatric COVID-19 Vaccines | Limited / Sole Source Justification | |
| Pediatric COVID-19 Vaccines | Award Notice | |
| This notice | Award Notice | |
| Pediatric COVID-19 Vaccines | Award Notice | |
| Pediatric COVID-19 Vaccines | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity